Evidence map›Paper›PMID 41108444›Full record

ArticleInternational journal of clinical pharmacy2026

Implementing a clinical pharmacy intervention for older adult inpatients with chronic non-cancer pain: a feasibility study.

Jasmin Abderhalden, Céline Lang, Carla Meyer-Massetti, Danja Müller, Patricia Cadisch, Dominic Bertschi, Aljoscha Noël Goetschi

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jasmin AbderhaldenClinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, Anna-Von-Krauchthal-Weg 7, 3010, Bern, Switzerland.ORCID http://orcid.org/0009-0003-4936-0410
Céline LangClinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, Anna-Von-Krauchthal-Weg 7, 3010, Bern, Switzerland.
Carla Meyer-MassettiClinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, Anna-Von-Krauchthal-Weg 7, 3010, Bern, Switzerland.ORCID http://orcid.org/0000-0002-3523-5729
Danja MüllerInstitute for Hospital Pharmacy, Bern University Hospital, 3010, Bern, Switzerland.
Patricia CadischInstitute for Hospital Pharmacy, Bern University Hospital, 3010, Bern, Switzerland.
Dominic BertschiDepartment of Geriatrics, Bern University Hospital, 3010, Bern, Switzerland.ORCID http://orcid.org/0000-0002-7978-5722
Aljoscha Noël GoetschiClinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, Anna-Von-Krauchthal-Weg 7, 3010, Bern, Switzerland. aljoscha.goetschi@insel.ch.ORCID http://orcid.org/0000-0002-9674-5124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionChronic non-cancer pain (CNCP) affects 22-88% of older adults and is associated with a lower quality of life and polypharmacy. It thus puts these already very vulnerable patients at a greater risk of medication-related harm.

aimThis feasibility study aimed to implement a multimodal clinical pharmacy intervention to improve CNCP-related care for older adult inpatients on hospital geriatrics wards.

methodWe conducted a single-arm feasibility study from January to May 2025, including patients aged 65 or older, hospitalised on the geriatrics ward of a tertiary hospital in Switzerland and previously diagnosed with CNCP. Feasibility was defined as the ability to perform the intervention as planned and approximated by recruitment and dropout rates. The intervention included semi-structured interviews about patients' pain histories, collected patient-reported outcome measures (PROMs) and recorded therapy goals. Pharmacists then conducted medication reviews using a previously developed and validated trigger tool. The trigger tool was used as a standardised approach for identifying medication-related issues, comprising a set of previously validated quality indicators. Findings were discussed during interprofessional ward rounds. Final treatment decisions were made jointly with patients. We followed up with patients by telephone one month after hospital discharge.

resultsOf 253 screened patients, we included 48 patients: 28 (58%) were interviewed, and 18 (38%) had a follow-up telephone call. Pharmacists suggested 56 therapy changes, with 29 identified by the trigger tool and 27 identified by regular medication review. Therapy change acceptance rates by the care team were 78% and 41%, respectively. Pain frequency and the highest and lowest pain levels over the last seven days all decreased after hospital discharge, although these changes cannot be causally attributed to the intervention. Other pain-related PROMs showed no change or just a slight improvement or deterioration.

conclusionThe present feasibility study showed that implementing a clinical pharmacy intervention for older adult inpatients was indeed feasible. However, the recruitment rates were relatively low, and dropout rates were relatively high. Using a standardised approach involving a trigger tool showed promising results for detecting medication-related problems. These are important first indicators that including pharmacists more closely in standard care could be beneficial to CNCP patients.

Indexed as

Chronic PainPharmacy Service, HospitalAgedAged, 80 and overFeasibility StudiesFemaleHumansInpatientsMalePharmacistsSwitzerlandChronic painClinical pharmacyFeasibility studyInterprofessional collaborationMedication safetyOlder adults

Identifiers

PMID41108444
PMCPMC12992365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.